Arm Holdings plc - American Depositary Shares (ARM)

Retail giant Walmart Inc. (NYSE:WMT) reported its fourth-quarter fiscal 2026 earnings on February 19, 2026, delivering a performance that exceeded analyst expectations on both revenue and earnings. Despite reaching a historic milestone of e-commerce profitability and announcing a massive $30 billion share repurchase program, the company’s stock faced

In a move that has sent shockwaves through the technology sector, Nvidia (NASDAQ: NVDA) and Meta Platforms (NASDAQ: META) have formalized a multi-year, multi-generational partnership to build what they describe as the world’s most advanced AI infrastructure. Announced on February 17, 2026, the deal signifies an unprecedented level of

Intermountain Children’s Health Launches the Nation’s Largest Pediatric Telestroke Network to Reduce Debilitating and Deadly Effects of Strokes in Children

In a move that underscores the shifting landscape of local commerce, Deutsche Bank has reaffirmed its "Buy" rating for DoorDash, Inc. (NASDAQ: DASH) as of February 19, 2026. The financial institution set a price target of $255, signaling a robust confidence in the company’s pivot from a simple food-delivery

On February 19, 2026, Wayfair (NYSE: W) released its fourth-quarter 2025 financial results, showcasing a robust performance that exceeded analyst expectations despite a persistently sluggish housing market. The e-commerce home furnishings giant reported a 7.4% increase in U.S. net revenue, a figure that highlights the company’s ability

These three consumer stocks look like solid buys.

Walmart Inc. (NYSE: WMT) reported a record-breaking fourth quarter for fiscal year 2025 today, surpassing analyst estimates on both the top and bottom lines driven by a surge in holiday spending and a robust e-commerce performance. Despite the revenue beat and the announcement of a massive $30 billion share buyback

The Fed's preferred measure of inflation will come out on Friday morning and could move markets.

NEW YORK — Pfizer Inc. (NYSE: PFE) has announced breakthrough results from its Phase 3 BREAKWATER clinical trial, demonstrating that its BRAFTOVI (encorafenib) regimen significantly improves both progression-free survival (PFS) and overall survival (OS) in patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC). The data, bolstered by a fresh topline report

In a move that has sent shockwaves through the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) for $180.00 per share in an all-cash transaction. The deal, valued at approximately $9.

As of February 19, 2026, EPAM Systems, Inc. (NYSE: EPAM) stands at a pivotal crossroads in its thirty-three-year history. Long regarded as the "gold standard" for high-end software engineering, the company has spent the last two years executing a massive strategic pivot. Having successfully navigated the geopolitical tremors of the early 2020s, EPAM is now [...]

One of these companies' services appears to be losing relevance. The other seems to be gaining it.

By Financial Research DeskFebruary 19, 2026 Introduction As of early 2026, Meta Platforms, Inc. (NASDAQ: META) has successfully navigated one of the most complex corporate transformations in modern history. Once defined solely by social media networking, the company has repositioned itself as a foundational "AI-first" utility. With a market capitalization comfortably hovering above $1.5 trillion, [...]

As of February 19, 2026, NVIDIA Corporation (NASDAQ: NVDA) stands as the undisputed gravitational center of the global technology ecosystem. Once known primarily as a niche provider of graphics hardware for PC gamers, the Santa Clara-based giant has evolved into the foundational architect of the "Intelligence Age." In early 2026, NVIDIA finds itself in a [...]

Date: February 19, 2026 Introduction In the global landscape of fintech, few stories are as compelling—or as profitable—as that of Nu Holdings Ltd. (NYSE: NU). Once a disruptive startup challenging the "Big Five" banking oligarchy in Brazil, Nu (commonly known as Nubank) has evolved into a financial superpower. As of early 2026, the company serves [...]

Beeline Holdings (NASDAQ: BLNE) announced the appointment of mortgage industry veteran Barry Levenson as Executive Strategic Advisor, where he will counsel the leadership team on capital strategy, loan economics, product positioning and funding efficiency initiatives aimed at supporting long-term profitability. Levenson brings more than 30 years of experience across mortgage banking, capital markets and funding strategy, including roles as founding principal and CEO of LK Secured Lending, managing director at PennyMac Financial Services and founding executive at Countrywide Bank. His appointment comes as Beeline pursues a stated objective of achieving a $100 million revenue run rate within 24 months, supported by disciplined capital management, product expansion and improved cost of funds.

Vancouver, British Columbia--(Newsfile Corp. - February 19, 2026) - Atomic Minerals Corporation (TSXV: ATOM) ("Atomic Minerals" or the "Company") announces...

VeloRESET has launched a weekly newsletter that gives baseball and softball players' parents a science-backed way to understand the movement patterns behind youth arm pain — before a sore elbow or lost velocity becomes harder to fix.​​​​​​​​​​​​​​​​

NextEra Energy and Southern Company are producing strong growth numbers and increasing dividends.

Brighthouse Financial sells life insurance, but that's not the big story driving the stock right now.

Dallas, Texas--(Newsfile Corp. - February 18, 2026) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on...

AUSTIN, Texas — In a quarterly earnings report that may be remembered as the moment the world’s most famous electric vehicle company formally shed its automotive skin, Tesla (NASDAQ: TSLA) has signaled a radical shift in its corporate DNA. On January 28, 2026, the company reported its fourth-quarter 2025 financial

Moleculin Biotech said on Wednesday that it is on track to treat the 45th patient with Annamycin as part of its Miracle study.

Arm Holdings shares are trading higher Wednesday despite new regulatory filings showing that Nvidia has exited its position in the chip designer.